Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial
CH Yen, YJ Chu, BJ Lee, YC Lin, PT Lin - British Journal of Nutrition, 2018 - cambridge.org
Ubiquinone is a lipid antioxidant, and a novel liquid ubiquinol (a hydro-soluble, reduced
form of coenzyme Q10) supplement was recently developed. The purpose of this study was
to examine the levels of glucose, lipids and antioxidant capacity of type 2 diabetes patients
after liquid ubiquinol supplementation. This study was designed as a randomised, double-
blind, placebo-controlled trial. In all, fifty participants were randomly assigned to a placebo
(n 25) or liquid ubiquinol (100 mg/d, n 25) group, and the intervention lasted for 12 weeks …
form of coenzyme Q10) supplement was recently developed. The purpose of this study was
to examine the levels of glucose, lipids and antioxidant capacity of type 2 diabetes patients
after liquid ubiquinol supplementation. This study was designed as a randomised, double-
blind, placebo-controlled trial. In all, fifty participants were randomly assigned to a placebo
(n 25) or liquid ubiquinol (100 mg/d, n 25) group, and the intervention lasted for 12 weeks …
Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial.
YCH Yen ChiHua, CYJ Chu YingJu, LBJ Lee BorJen… - 2018 - cabidigitallibrary.org
Ubiquinone is a lipid antioxidant, and a novel liquid ubiquinol (a hydro-soluble, reduced
form of coenzyme Q10) supplement was recently developed. The purpose of this study was
to examine the levels of glucose, lipids and antioxidant capacity of type 2 diabetes patients
after liquid ubiquinol supplementation. This study was designed as a randomised, double-
blind, placebo-controlled trial. In all, fifty participants were randomly assigned to a placebo
(n 25) or liquid ubiquinol (100 mg/d, n 25) group, and the intervention lasted for 12 weeks …
form of coenzyme Q10) supplement was recently developed. The purpose of this study was
to examine the levels of glucose, lipids and antioxidant capacity of type 2 diabetes patients
after liquid ubiquinol supplementation. This study was designed as a randomised, double-
blind, placebo-controlled trial. In all, fifty participants were randomly assigned to a placebo
(n 25) or liquid ubiquinol (100 mg/d, n 25) group, and the intervention lasted for 12 weeks …
以上显示的是最相近的搜索结果。 查看全部搜索结果